Aim to Reduce Movements in Tardive Dyskinesia
Clinical trial NCT02195700 · COMPLETED
Trial details
- NCT number
- NCT02195700
- Sponsor
- Auspex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-05-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.